1. Lainesse C, Gehring R, Pasloske K, Smith G, Soback S, Wagner S, et al. Challenges associated with the demonstration of bioequivalence of intramammary products in ruminants. J Vet Pharmacol Ther. 2012;35(Suppl 1):65–79.
2. Blowey RW, Edmondson P. Mastitis control in dairy herds. 2nd ed: Cabi; 2010.
3. Office of New Animal Drug Evaluation, FDA Center for Veterinary Medicine, U.S. Food and Drug Administration. Approved animal drug products (Green Book). Maryland, U.S.A. 2024, [Available from: https://animaldrugsatfda.fda.gov/adafda/views/#/search].
4. Office of New Animal Drug Evaluation, FDA Center for Veterinary Medicine, U.S. Food & Drug Administration (FDA). Administrative applications and the phased review process: Guidance for industry. (Docket No. FDA-2002-D-0147). Maryland, U.S.A. 2018, [Available from: https://www.fda.gov/media/70029/download].
5. Animals Drugs @ FDA, FDA Center for Veterinary Medicine, U.S. Food & Drug Administration (FDA). Dry-Clox® Intramammary Infusion-cloxacillin benzathine gel Boehringer lngelheim Animal Health USA Inc. (NADA: N55058). Maryland, U.S.A. 2017 [Available from: https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/055-058].